Market closedNon-fractional

Affimed/AFMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Affimed

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Ticker

AFMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Mannheim, Germany

Employees

76

Affimed Metrics

BasicAdvanced
$83M
Market cap
-
P/E ratio
-$6.73
EPS
2.04
Beta
-
Dividend rate
$83M
2.04
3.06
2.685
22.787
39.522
-52.01%
-46.12%
-112.37%
7.443
1.91
1.91
-0.664
-76.27%
-8.73%
-36.01%
22.21%

What the Analysts think about Affimed

Analyst Ratings

Majority rating from 8 analysts.
Buy

Affimed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-5,050.00% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€400K
-78.95%
Net income
-€20M
-16.87%
Profit margin
-5,050.00%
294.86%

Affimed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 12.50%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-€2.10
-€2.00
-€1.60
-€1.35
-
Expected
-€1.96
-€1.89
-€1.84
-€1.54
-€1.57
Surprise
7.40%
5.62%
-13.26%
-12.50%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Affimed stock?

Affimed (AFMD) has a market cap of $83M as of July 06, 2024.

What is the P/E ratio for Affimed stock?

The price to earnings (P/E) ratio for Affimed (AFMD) stock is 0 as of July 06, 2024.

Does Affimed stock pay dividends?

No, Affimed (AFMD) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Affimed dividend payment date?

Affimed (AFMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Affimed?

Affimed (AFMD) has a beta rating of 2.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Affimed stock

Buy or sell Affimed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing